Oren Gilad

Insider Reports History

Location
Boston, MA
Signature
/s/ John P. Hamill, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Oren Gilad:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aprea Therapeutics, Inc. President/CEO, Director Common Stock 373,720 $332,610 $0.8900 30 Jan 2026 Direct
Aprea Therapeutics, Inc. President/CEO, Director Pre-Funded Warrant 21,459 $24,999 $1.16 10 Dec 2025 Direct
Aprea Therapeutics, Inc. President/CEO, Director Common Stock 1,200 $1,104 $0.9200 30 Jan 2026 By Daughter
Aprea Therapeutics, Inc. President/CEO, Director Common Stock 600 $552 $0.9200 30 Jan 2026 By Son
Aprea Therapeutics, Inc. President/CEO, Director Common Warrant 28,100 30 Jan 2026 Direct
Aprea Therapeutics, Inc. President/CEO, Director Stock Options (Right to Buy) 26,900 27 Mar 2025 Direct
Aprea Therapeutics, Inc. President/CEO, Director Common Warrants 21,459 10 Dec 2025 Direct

Insider Reports Filed by Oren Gilad

Symbol Company Period Transactions Value $ Form Type Role Filing Time
APRE Aprea Therapeutics, Inc. 30 Jan 2026 2 +$25,009 4 President/CEO, Director 02 Feb 2026, 16:08
APRE Aprea Therapeutics, Inc. 10 Dec 2025 2 +$25,000 4 President/CEO, Director 11 Dec 2025, 08:30
APRE Aprea Therapeutics, Inc. 03 Apr 2025 2 +$10,110 4 President/CEO, Director 04 Apr 2025, 07:30
APRE Aprea Therapeutics, Inc. 27 Mar 2025 2 $0 4 President/CEO, Director 31 Mar 2025, 16:30
APRE Aprea Therapeutics, Inc. 23 Oct 2024 1 +$1,958 4 President/CEO, Director 24 Oct 2024, 08:30
APRE Aprea Therapeutics, Inc. 15 Oct 2024 1 +$725 4 President/CEO, Director 16 Oct 2024, 08:31
APRE Aprea Therapeutics, Inc. 10 Oct 2024 2 +$2,971 4 President/CEO, Director 15 Oct 2024, 08:31
APRE Aprea Therapeutics, Inc. 28 Mar 2024 2 $0 4 President, CEO, Director 28 Mar 2024, 17:57
APRE Aprea Therapeutics, Inc. 13 Mar 2024 3 +$14,580 4 President, CEO, Director 14 Mar 2024, 20:51
APRE Aprea Therapeutics, Inc. 23 Aug 2022 4 $0 4 President, CEO, Director 13 Mar 2023, 18:30
APRE Aprea Therapeutics, Inc. 28 Jul 2022 2 $0 4 President, CEO 01 Aug 2022, 17:01
APRE Aprea Therapeutics, Inc. 16 May 2022 0 $0 3 President, Director 26 May 2022, 16:15